Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study

Lupus

Volumn 21, Issue 4, 2012, Pages 452-459

  Bengtsson, C ^a   Ohman M L ^b   Nived, O ^a   Dahlqvist, S Rantapää ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

atherosclerosis; cardiovascular incidence; epidemiology; outcome research; predictors; systemic lupus erythematosus

Indexed keywords

ANTIHYPERTENSIVE AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; SEX; SMOKING HABIT; STANDARD INCIDENCE RATIO; STROKE; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84858673576     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311425524     Document Type: Article

References (38)

1. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality in SLE. Am J Med. 1976 ; 60: 221-225
2. Ward MM. Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosus. Arthritis Rheum. 1999 ; 42: 338-346 (Pubitemid 29072852)
3. Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004 ; 93: 198-200 (Pubitemid 38058729)
4. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum. 2009 ; 61: 1396-1402
5. Jonson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989 ; 68: 141-150 (Pubitemid 19132411)
6. Manzi S, Meilhan EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol. 1997 ; 145: 408-415 (Pubitemid 27084212)
7. Bessant R, Duncan R, Ambler G, et al. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2006 ; 55: 892-899 (Pubitemid 44917462)
8. Petri M, Perez-Gutthan S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992 ; 93: 513-519
9. Svenungsson E, Jensen-Urstad K, Heimbürger M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001 ; 104: 1887-1893 (Pubitemid 32983229)
10. Urowitz MB, Ibañez D, Gladman DD. Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol. 2007 ; 34: 70-75 (Pubitemid 46106565)
11. Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients from a defined population. Medicine. 1992 ; 71: 216-223
12. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
13. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 363-369 (Pubitemid 26085211)
14. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 11: 1271-1277 (Pubitemid 13221242)
15. Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
16. Bessant R, Hingorani A, Patel A, MacGregor A, Isenberg DA, Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology. 2004 ; 43: 924-929 (Pubitemid 38996970)
17. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001 ; 44: 2215-2217
18. Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol Suppl. 1987 ; 14: 223-226
19. Gustafsson J, Gunnarsson I, Börjesson O, et al. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus-a prospective cohort study. Arthritis Res Ther. 2009 ; 11: R186 - R186
20. Urowitz MB, Gladman D, Ibañez D, et al. Atherosclerotic vascular events in a multinational cohort of systemic lupus erythematosus. Arthritis Care Res. 2010 ; 62: 881-887
21. Bruce IN, Urowitz MB, Gladman DD, Ibañez D, Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus. Arthritis Rheum. 2003 ; 48: 3159-3167 (Pubitemid 37409327)
22. Goldberg RJ, Urowitz MB, Ibañez D, Nikpour M, Gladman DD. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. J Rheumatol. 2009 ; 36: 2454-2461
23. Ruiz-Irastora G, Ramos-Casals M, Brito-Zeron P, Khamasta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis. 2010 ; 69: 20-28
24. Svenungsson E, Gustafsson J, Leonard D, et al. A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010 ; 69: 834-840
25. Toloza SM, Uribe AG, McGwin G, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII: Baseline predictors of vascular events. Arthritis Rheum. 2004 ; 50: 3947-3957 (Pubitemid 39643943)
26. Nojima J, Masuda Y, Iwatani Y, et al. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/β2-glycoprotein I antibodies as a strong risk factor tor ischaemic heart disease in patients with systemic lupus erythematosus. Rheumatology. 2008 ; 47: 684-689 (Pubitemid 351619213)
27. Petri M. Update on anti-phospholipid antibodies on SLE: the Hopkins' lupus cohort. Lupus. 2010 ; 19: 419-423
28. Roubey RAS. Risky business: the interpretation, use and abuse of antiphospholipid antibody tests in clinical practice. Lupus. 2010 ; 19: 440-445
29. Devreese K, Hoylaerts MF. Challenge in the diagnosis of the antiphospholipid syndrome. Clin Chem. 2010 ; 56: 930-940
30. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rhem. 1999 ; 42: 51-60 (Pubitemid 29042570)
31. Roman MJ, Shanker B-A, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 2399-2406 (Pubitemid 37542988)
32. Roman MJ, Crow MK, Lockshin MD, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2007 ; 56: 3412-3419 (Pubitemid 47585436)
33. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 2407-2415 (Pubitemid 37542989)
34. Hallengren C, Bengtsson A, Nived O, Sturfelt G. Incidence studies of SLE in southern Sweden: increasing age, decreasing frequency of renal manifestations, and good prognosis. J Rheumatol. 2000 ; 27: 685-691 (Pubitemid 30151347)
35. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheum. 1998 ; 27: 98-105 (Pubitemid 28172565)
36. Uramoto KM, Michet CJ, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus, 1985-1992. Arthritis Rheum. 1999 ; 42: 46-50 (Pubitemid 29042569)
37. Hopkinson ND, Doherty M, Pwell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol. 1993 ; 32: 110-115 (Pubitemid 23077694)
38. Nossent HC. Systemic lupus erythematosus in the arctic region of Norway. J Rheumatol. 2001 ; 28: 539-546 (Pubitemid 32202656)